文献速递甲状腺核医学

多期碘对比增强SPECT/CT在小型甲状旁腺腺瘤术前定位中优于非增强SPECT/CT

Multiphase Iodine Contrast-Enhanced SPECT/CT Outperforms Nonenhanced SPECT/CT for Preoperative Localization of Small Parathyroid Adenomas.
PubMed 文献 · Clin Nucl Med · 2019-01-01

结果显示,加入对比增强CT使灵敏度从81.1%提高至89.9%(P=0.003),特异性与非增强SPECT/CT相似(96.1% vs 97.9%;P=0.077)。

要点

  • 对比增强CT使整体灵敏度从81.1%提升至89.9%,差异有统计学意义(P=0.003)。
  • 特异性非增强与增强SPECT/CT相似(96.1% vs 97.9%;P=0.077)。
  • 单腺体病变患者灵敏度从86.4%升至93.6%(P=0.021)。

核心结论

  • 在腺瘤普遍较小的队列中,Tc-MIBI SPECT/CT加入对比增强CT可大幅提高术前定位灵敏度。

研究设计与样本

  • 采用双时间点(10和90分钟)协议,并采集非增强CT及对比剂注射开始后35秒动脉期和75秒静脉期的对比增强CT。
  • 149例患者的影像结果可与手术及组织病理学结果对照。

主要发现

  • 中位腺瘤重量为330 mg。
  • 加入对比增强CT使灵敏度从81.1%提高至89.9%(P=0.003)。
  • 非增强SPECT/CT与对比增强CT的特异性相似(96.1% vs 97.9%;P=0.077)。
  • 单腺体病变患者(n=140,94.0%)加入对比增强CT后灵敏度从86.4%提高至93.6%(P=0.021),特异性从96.2%提高至97.9%(P=0.118)。
  • 多腺体病变患者(n=9,6.0%)加入对比增强CT后检测灵敏度从42.1%提高至63.2%,但未达统计学显著(P=0.125)。

临床怎么用

  • 对于拟行术前定位的小型甲状旁腺腺瘤患者,可在Tc-MIBI SPECT/CT基础上加入多期对比增强CT以提高定位灵敏度。

局限性

  • 多腺体病变患者仅9例(6.0%),加入对比增强CT的灵敏度改善未达统计学显著(P=0.125)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to assess the value of intravenously contrast-enhanced CT in conjunction with Tc-MIBI SPECT for preoperative localization of parathyroid adenoma. METHODS: One hundred ninety-two patients with primary hyperparathyroidism were enrolled in the study between May 2015 and May 2017. The patients underwent a preoperative "one-stop shop" examination with Tc-MIBI SPECT/CT by using dual time-point (10 and 90 minutes) protocol and both nonenhanced CT and contrast-enhanced CT acquisition in the arterial and venous phase, 35 and 75 seconds, respectively, after contrast medium injection start. For 149 patients, the imaging results could be correlated to those at surgery and histopathology. RESULTS: The median adenoma weight was 330 mg. The addition of contrast-enhanced CT increased the sensitivity from 81.1% to 89.9% (P = 0.003). The specificity of nonenhanced SPECT/CT was similar to contrast-enhanced CT (96.1% vs 97.9%; P = 0.077). For patients with uniglandular disease (n = 140, 94.0%), the sensitivity increased from 86.4% to 93.6% (P = 0.021) and the specificity from 96.2% to 97.9% (P = 0.118) by adding contrast-enhanced CT. In patients with multiglandular disease (n = 9, 6.0%), adding contrast-enhanced CT improved detection sensitivity from 42.1% to 63.2%. However, these patients were few and significance was not reached (P = 0.125). CONCLUSIONS: In this cohort, with generally small parathyroid adenomas, the sensitivity in preoperative localization was greatly improved by adding contrast-enhanced CT to Tc-MIBI SPECT/CT.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sandqvist P, Nilsson IL, Grybäck P, et al. Multiphase Iodine Contrast-Enhanced SPECT/CT Outperforms Nonenhanced SPECT/CT for Preoperative Localization of Small Parathyroid Adenomas. Clin Nucl Med. 2019. PMID: 31689274. doi:10.1097/RLU.0000000000002778

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。